Medicines Discovery Catapult is a national Life Sciences service.
We create momentum through our unique blend of discovery expertise, technology, insights, and sector-leading partnerships.
Antimicrobial Resistance (AMR) is one of the fastest-developing threats to global health. By 2050, AMR is projected to cause over 39 million deaths , with drug-resistant infections already making common illnesses much harder to treat. Urgently rethinking how we tackle AMR is now a necessity, as without effective antibiotics and diagnostics, modern medicine is at risk.
Learn more
Total-body PET allows highly sensitive dynamic imaging of the whole human body in near real-time. With dynamic, high-resolution scans and significantly lower radiation exposure, Total-body PET opens the door to new insights into multi-organ disease progression, radiotracer pharmacokinetics, and systemic treatment effects, all in a single scan.
Learn more
Nearly one billion people worldwide suffer from some form of mental health disorder, impacting quality of life, productivity and long-term well-being. Despite the growing need for effective treatments, mental health drug discovery has faced persistent challenges: a limited number of validated targets, a lack of predictive preclinical models, and high clinical trial failure rates.
Learn more
RNA Therapeutics are redefining what is possible in drug discovery. They offer opportunities for an improved side effect profile and efficacy against previously intractable targets. RNA Therapeutics aim to treat diseases by targeting gene expression or producing therapeutic proteins.
Learn more
See how we can help support you with your next drug discovery project.
Speak to us